NFKB1 and chronic inflammatory demyelinating polyradiculoneuropathy: Moreover, we observed that fingolimod modulated inflammatory cytokines and affected the Akt/mTOR/NF‐κB axis in c‐EAN rats, which could be beneficial for CIDP patients.